Irina P. Nikishina
Moscow, MOW, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Pharmacokinetics, Effectiveness and Safety of Certolizumab Pegol in Children and Adolescents With Active Juvenile Idiopathic Arthritis: 9+-Year Results From a Multicenter, Open-Label Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 28, 2026
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+-year results from a multicenter, open-label study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 28, 2026
Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 15, 2025
Predictors of inactive disease and remission in children and young adults with juvenile idiopathic arthritis treated with etanercept.
Journal: Rheumatology (Oxford, England)
Published: July 24, 2025
Juvenile arthritis damage index predicts poor response to biological treatment: A prospective cohort study.
Journal: World journal of clinical pediatrics
Published: April 24, 2025
Assessment of the Damage Index and Its Dynamics in Patients with Non-Systemic Variants of Juvenile Arthritis during the Treatment with Biologics.
Journal: Doklady. Biochemistry and biophysics
Published: February 03, 2025
Sarilumab in Polyarticular-Course Juvenile Idiopathic Arthritis: Dose-Finding and 1-Year Analysis of a Phase 2b, Open-Label, Multicenter Study.
Journal: Arthritis care & research
Published: January 22, 2025
Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.
Journal: Rheumatology (Oxford, England)
Published: November 29, 2023
Successful experience of tofacitinib treatment in patients with Fibrodysplasia Ossificans Progressiva.
Journal: Pediatric rheumatology online journal
Published: May 03, 2023
Definition and Validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score Cutoffs for Disease Activity States in Juvenile Idiopathic Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 26, 2021
INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry.
Journal: The journal of allergy and clinical immunology. In practice
Published: June 03, 2020
Last Updated: 09/26/2026